Home/Filings/4/0001822879-25-000006
4//SEC Filing

Leonard Frank X 4

Accession 0001822879-25-000006

CIK 0001645113other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:09 PM ET

Size

5.3 KB

Accession

0001822879-25-000006

Insider Transaction Report

Form 4
Period: 2025-11-01
Leonard Frank X
EVP, Pres., Novocure Oncology
Transactions
  • Tax Payment

    Ordinary Shares

    2025-11-01$12.81/sh966$12,374347,745 total
Footnotes (1)
  • [F1]Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001822879

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:09 PM ET
Size
5.3 KB